Advancing antisense oligonucleotide delivery through click chemistry based chemical conjugation with designed short non-cationic peptides for Duchenne muscular dystrophy.

Ghosh, Surojit et al.·Methods (San Diego·2025·
RPEP-110962025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Advancing antisense oligonucleotide delivery through click chemistry based chemical conjugation with designed short non-cationic peptides for Duchenne muscular dystrophy.
Published In:
Methods (San Diego, Calif.), 244, 92-107 (2025)
Database ID:
RPEP-11096

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-11096·https://rethinkpeptides.com/research/RPEP-11096

APA

Ghosh, Surojit; Arshi, Mohammad Umar; Ghosh, Satyajit; Jash, Moumita; Mukherjee, Nabanita; Jana, Aniket; Shastry, Arun; Karanth, Deepika; Nishad, Khushbu; Rana, Nirmal Kumar; Bhattacharyya, Sudipta; Ghosh, Surajit. (2025). Advancing antisense oligonucleotide delivery through click chemistry based chemical conjugation with designed short non-cationic peptides for Duchenne muscular dystrophy.. Methods (San Diego, Calif.), 244, 92-107. https://doi.org/10.1016/j.ymeth.2025.09.005

MLA

Ghosh, Surojit, et al. "Advancing antisense oligonucleotide delivery through click chemistry based chemical conjugation with designed short non-cationic peptides for Duchenne muscular dystrophy.." Methods (San Diego, 2025. https://doi.org/10.1016/j.ymeth.2025.09.005

RethinkPeptides

RethinkPeptides Research Database. "Advancing antisense oligonucleotide delivery through click c..." RPEP-11096. Retrieved from https://rethinkpeptides.com/research/ghosh-2025-advancing-antisense-oligonucleotide-delivery

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.